The aim of the study was to prospectively gather data on the outcomes of prenatally diagnosed Trisomy 21 (T21) in a large tertiary referral centre. Our aim was to examine the termination rate and the rate of fetal loss in those who chose to continue including miscarriage and stillbirth. STUDY DESIGN: Data was gathered prospectively in a large tertiary referral centre over 5 years from 2013-2017 inclusively. Baseline demographic and delivery details were recorded on an anonymized computerized database, these data are subject to continuous audit. The gestation at diagnosis, associated anomalies and the nature of diagnostic tests were recorded. Outcomes including termination of pregnancy (TOP), miscarriage, stillbirth and neonatal death were recorded. The mode of delivery and associated complications were also recorded. Unpaired t-tests were used to compare continuous data and chi-square tests to compare categorical data. Multiple logistic regression was used to calculate adjusted odds ratios. RESULTS: There were a total of 44,750 deliveries in the study period. There were 1836 congenital anomalies diagnosed in the study period including 165 (8.9%) cases of Trisomy 21. There was incidence therefore of 0.3% or 1 in 330 for prenatally diagnosed T21. Full outcome data was available in 112 cased. 76 (67%) women choose a termination of pregnancy following a diagnosis of T21. There were 4 second trimester miscarriages (11%) and 10 stillbirths (27%) in those that did not undergo a termination of pregnancy. The total fetal loss rate in those that did not undergo termination was 38%. CONCLUSION: T21 is one of the most common conditions encountered in fetal medicine. In this jurisdiction termination of pregnancy is illegal at present and requires travel abroad, leading to a lower termination rate. This allows the natural history to be observed. The risk of fetal loss in prenatally diagnosed T21 is relatively high at 30%. This information may be of benefit when counselling those who choose to continue their pregnancy or in settings where there is limited access to termination of pregnancy.
OBJECTIVE:
The Management of Myelomeningocele Study (MOMS) trial reported that in utero fetal surgery for myelomeningocele repair (fMMC) resulted in reversal of hindbrain herniation and decreased need for ventriculoperitoneal shunt (VPS). Fetuses with preoperative ventricle size (VS) ! to 15 mm, however, were less likely to realize this benefit. In this study, we analyzed the trend in VS throughout gestation to determine whether it is a predictor of VPS. STUDY DESIGN: This is a secondary analysis of prospectively collected data of consecutive cases with fetal myelomeningocele evaluated and delivered at our institute (January 2012 to May 2018). VS measurements were obtained as outlined by the ISUOG guidelines and reviewed by the Fetal Surgeons. Women with initial VS ! 15 mm were excluded. Two groups were identified: Group 1 -women who had fetal surgery (fMMC), Group 2 -women whose neonates had postnatal repair (PNR). Criteria for VPS was similar for both groups. Ultrasound measurements of VS for each 2-week epoch of gestational age (GA) were compared between the groups. Penalized Bsplines were used to fit the VS data over GA for each group. To determine whether VS was predictive of postnatal VPS, receiver operator curves (ROCs) were used to determine the optimal VS cutoff values for each 2-week epoch. Sensitivity (SN), specificity (SP), positive predictive value (PPV), negative predictive value (NPV) and positive/negative likelihood ratios (LLR) were calculated at the cutoffs determined by the ROCs. RESULTS: 95 women met inclusion criteria; 55 (58%) had fMMC repair and 40 (42%) had PNR. VPS rates were 36% and 65% respectively (p < 0.01). VS was similar between each group at all GAs except for 30 e 32 weeks (18.3 AE 5.6 vs. 14.3 AE 6.8, p < 0.01 Table 1 . Penalized B-splines show VS increasing continuously with GA for each group (Figure 1 ). ROC analysis showed that VS at 28 e 30 weeks is most predictive of VPS (area under ROC ¼ 0.70, 95% CI 0.55 e 0.86). At this GA, a VS cutoff of 18 mm had SN of 60%, SP of 89%, PPV of 83%, and NPV of 71% for prediction of VPS (LLR+ 5.5, Table1) . Test statistics at other GA epochs were similar and the optimal cutoff increased continuously with GA. CONCLUSION: Overall VS is weakly predictive of the need for postnatal VPS. However, at 28 e 30 weeks GA, fetuses with VS greater than 18 mm are at moderately increased risk of requiring postnatal VPS. Postnatal factors resulting in the increased need for VPS in the PNR group needs to be assessed further.
OBJECTIVE: Biweekly surveillance ultrasound (US) examination is a strategy recommended to detect early twin-twin transfusion syndrome (TTTS) in monochorionic-diamniotic (MCDA) twins. However, data to support this frequency of surveillance are scarce. Our objective was to determine whether a biweekly scanning paradigm can reliably detect TTTS at an early stage (i.e. < Quintero stage II). STUDY DESIGN: This is a retrospective cohort study of women with MCDA twin pregnancies whose first US exam occurred at our center between 2012 and 2018. Women with uncertain chorionicity, less than 2 serial US exams, or those followed outside of our healthcare system were excluded. Routine surveillance consisted of an US exam every 2 weeks starting at 16 weeks gestational age (GA). Univariate analysis of US exam patterns and pregnancy characteristics was performed comparing women that had TTTS to those who did not. For women diagnosed after at least one normal US examination, GA and Quintero stage at diagnosis and length of time since the last normal US exam was determined to assess whether the frequency of US examination was adequate. To assess whether the initial screening US was early enough to detect evolving TTTS, women diagnosed with TTTS on their first US were considered separately. RESULTS: Of 409 women with MCDA twins that met inclusion criteria, 46 (11.3%) developed TTTS. Women with TTTS had less time between scans (7.4 AE 7.6 vs. 12.7 AE 8.0 days, p < 0.01), but baseline characteristics were otherwise similar between the groups (Table 1) . Among women with TTTS, 25 (54.4%) were diagnosed at their first US while 21 (46.6%) were diagnosed at a later US. Those diagnosed at the first US had similar GA (20.3 AE 3.8 vs. 22.3 AE 4.9, p ¼ 0.16) and Quintero stage (median II vs. III, p ¼ 0.34) as those diagnosed at a later US exam. The majority of TTTS detected after at a later US (i.e. >1 US) was diagnosed within 2 weeks of the last normal US (16/21, 76%). Most of these twins (9/ 16, 56%, p ¼ 0.09) had stage II or greater disease on diagnosis (Figure 1) . CONCLUSION: In this cohort of women that had biweekly ultrasounds, most cases of TTTS were detected at an advanced stage (Quintero stage > I). This suggests that biweekly US alone is not adequate to diagnose early TTTS. Further research is required to determine whether more frequent US screening may improve early detection. For women diagnosed on first US, it is unclear from this analysis whether earlier US would detect TTTS earlier.
191 The natural history of selective intrauterine growth restriction in monochorionic-diamniotic twins Table 1 ). Little is known on the natural history of sIUGR based on the Barcelona classification and management recommendations. (Valsky DV 2010) . Here we present a case series of twins with sIUGR as it evolved during gestation. STUDY DESIGN: This is a retrospective cohort study of MCDA twin pregnancies whose first ultrasound examination occurred at our center between 2013 and 2018. Women with uncertain chronicity, less than 2 surveillance ultrasounds at our center, or those followed at an outside location were excluded. Fetuses with twin-twin transfusion syndrome were also excluded. Routine surveillance consisted of an ultrasound every 2 weeks starting at 16 weeks gestational age (GA). sIUGR was defined by growth discordance of 25% or greater and Gratacós stage was determined by UA Doppler flow pattern. We compared gestational age of diagnosis, the perinatal outcome based on the sIUGR type. RESULTS: Of 409 women with MCDA twins that met inclusion criteria, 67 (14.4%) developed sIUGR. Among these, 54 (80.6%) were type I, 9 (13.4%) were type II and, and 4 (6.0%) were type III sIUGR at the time of diagnosis. Diagnoses were made in 28 (42%) at 16 e 20 weeks GA, 16 (24%) at 20 e 24 weeks GA The remaining 23 cases (34%) were detected throughout the third trimester with one diagnosis > 36 weeks GA (Figure 1 ). The majority of type II and III cases (n ¼ 7, 54%) were diagnosed prior to 20 weeks, however GA at diagnosis between types was similar (p ¼ 0.83). Of twins with type I sIUGR 9 (17%) cases resolved spontaneously, whereas 1 (9%) of twins with types II or III appeared to resolve. Rates of demise of the smaller twin were similar between each type of sIUGR (p ¼ 0.46,
